Urinary Tract Effects of HPSE2 Mutations


Autoria(s): Stuart, H; Roberts, N; Hilton, E; McKenzie, E; Daly, S; Hadfield, K; Rahal, J; Gardiner, N; Tanley, S; Lewis, M; Sites, E; Angle, B; Alves, C; Lourenço, T; Rodrigues, M; Calado, A; Amado, M; Guerreiro, N; Serras, I; Beetz, C; Varga, R; Silay, M; Darlow, J; Dobson, M; Barton, D; Hunziker, M; Puri, P; Feather, S; Goodship, J; Goodship, T; Lambert, H; Cordell, H; Saggar, A; Kinali, M; Lorenz, C; Moeller, K; Schaefer, F; Bayazit, A; Weber, S; Newman, W; Woolf, A
Data(s)

24/05/2016

24/05/2016

01/04/2015

Resumo

Urofacial syndrome (UFS) is an autosomal recessive congenital disease featuring grimacing and incomplete bladder emptying. Mutations of HPSE2, encoding heparanase 2, a heparanase 1 inhibitor, occur in UFS, but knowledge about the HPSE2 mutation spectrum is limited. Here, seven UFS kindreds with HPSE2 mutations are presented, including one with deleted asparagine 254, suggesting a role for this amino acid, which is conserved in vertebrate orthologs. HPSE2 mutations were absent in 23 non-neurogenic neurogenic bladder probands and, of 439 families with nonsyndromic vesicoureteric reflux, only one carried a putative pathogenic HPSE2 variant. Homozygous Hpse2 mutant mouse bladders contained urine more often than did wild-type organs, phenocopying human UFS. Pelvic ganglia neural cell bodies contained heparanase 1, heparanase 2, and leucine-rich repeats and immunoglobulin-like domains-2 (LRIG2), which is mutated in certain UFS families. In conclusion, heparanase 2 is an autonomic neural protein implicated in bladder emptying, but HPSE2 variants are uncommon in urinary diseases resembling UFS.

Identificador

J Am Soc Nephrol. 2015 Apr;26(4):797-804

http://hdl.handle.net/10400.17/2500

10.1681/ASN.2013090961

Idioma(s)

eng

Publicador

American Society of Nephrology

Direitos

openAccess

Palavras-Chave #Animals #Facies #Female #Glucuronidase #Humans #Male #Mice #Mice, Inbred C57BL #Mutation #Urinary Tract #Urologic Diseases #HDE GEN
Tipo

article